Suppr超能文献

一种新型垂体因子增强雌激素对人乳腺癌细胞促有丝分裂作用的证据。

Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.

作者信息

Dembinski T C, Leung C K, Shiu R P

出版信息

Cancer Res. 1985 Jul;45(7):3083-9.

PMID:4005846
Abstract

Estrogen, prolactin, and other tissue-derived factors are implicated in the etiology and pathophysiology of human breast cancer (HBC). In a previous study, we demonstrated that a factor(s) secreted by rat pituitary tumor cells (GH3) synergizes with estrogen to induce growth of HBC cells (T-47D) transplanted into athymic nude mice. The present studies were carried out to characterize further this pituitary growth factor. Pituitary tumor cell lines (GH3, GH1, 235-1, and AtT-20) and normal rat pituitaries were transplanted s.c. into estrogen-treated (estradiol valerate injection, 500 micrograms/14 days) athymic nude mice which also received T-47D cells. The influence of the presence of these normal and tumorous pituitary cells on growth (size and weight) of T-47D tumors was monitored for 49 to 56 days. The results indicate that factor(s) from normal rat pituitary glands as well as from the GH1 and GH3 but not 235-1 and AtT-20 pituitary tumor cells were able to potentiate the growth of T-47D tumors in estrogenized mice. To ascertain whether or not prolactin and/or growth hormone are responsible for the growth-promoting activity, purified human and ovine growth hormone and ovine prolactin were administered to estrogenized athymic nude mice either by daily s.c. injection (100 micrograms/day) or by constant infusion using Alzat osmotic minipumps (1.25 and 5.0 micrograms/h) for 29 to 56 days. None of these treatments stimulated the growth of the T-47D tumors, suggesting that prolactin, growth hormone, and their intermediates may not be directly involved. We further determined whether the factor from pituitary tumor cells was present in serum-free conditioned medium and could stimulate the growth of HBC cells in vitro. Conditioned medium from GH3 and GH1 but not from 235-1 and AtT-20 pituitary cells significantly stimulated growth of T-47D cells in the presence of estradiol (10(-10) M) after 12 days of culture in a serum-free medium (Dulbecco's modified Eagle's medium containing bovine serum albumin, 0.5 mg/ml). Optimal serum-free growth of T-47D cells (2-fold above control) was observed in the presence of estradiol (10(-10) M) and conditioned medium (30% v/v) from 48-h cultures of GH3 cells. The bovine serum albumin concentration of the serum-free medium (Dulbecco's modified Eagle's medium) was also important: optimal T-47D cell proliferation was observed with BSA between 0.5 and 2.0 mg/ml. Conditioned medium preparations from serum-pretreated flasks (without cells) from GH3 cell monolayers for zero time and from actinomycin D plus cycloheximide-inhibited GH3 cells were inactive.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

雌激素、催乳素及其他组织衍生因子与人类乳腺癌(HBC)的病因及病理生理学有关。在之前的一项研究中,我们证明大鼠垂体肿瘤细胞(GH3)分泌的一种因子能与雌激素协同作用,诱导移植到无胸腺裸鼠体内的HBC细胞(T - 47D)生长。本研究旨在进一步表征这种垂体生长因子。将垂体肿瘤细胞系(GH3、GH1、235 - 1和AtT - 20)以及正常大鼠垂体皮下移植到经雌激素处理(戊酸雌二醇注射,500微克/14天)的无胸腺裸鼠体内,这些裸鼠也接种了T - 47D细胞。在49至56天内监测这些正常和肿瘤性垂体细胞的存在对T - 47D肿瘤生长(大小和重量)的影响。结果表明,来自正常大鼠垂体以及GH1和GH3但不是235 - 1和AtT - 20垂体肿瘤细胞的因子能够增强雌激素化小鼠体内T - 47D肿瘤的生长。为确定催乳素和/或生长激素是否负责这种促生长活性,将纯化的人及羊生长激素和羊催乳素通过每日皮下注射(100微克/天)或使用Alzat渗透微型泵持续输注(1.25和5.0微克/小时)给予雌激素化的无胸腺裸鼠,持续29至56天。这些处理均未刺激T - 47D肿瘤生长,提示催乳素、生长激素及其中间体可能未直接参与。我们进一步确定垂体肿瘤细胞分泌的因子是否存在于无血清条件培养基中,以及是否能在体外刺激HBC细胞生长。在无血清培养基(含有0.5毫克/毫升牛血清白蛋白的杜氏改良 Eagle培养基)中培养12天后,来自GH3和GH1但不是235 - 1和AtT - 20垂体细胞的条件培养基在存在雌二醇(10⁻¹⁰ M)的情况下显著刺激了T - 47D细胞生长。在存在雌二醇(10⁻¹⁰ M)和来自GH3细胞48小时培养物的条件培养基(30% v/v)时,观察到T - 47D细胞的最佳无血清生长(比对照高2倍)。无血清培养基(杜氏改良 Eagle培养基)中牛血清白蛋白的浓度也很重要:在牛血清白蛋白浓度为0.5至2.0毫克/毫升时观察到T - 47D细胞的最佳增殖。来自GH3细胞单层零时间血清预处理培养瓶(无细胞)以及放线菌素D加环己酰亚胺抑制的GH3细胞的条件培养基制剂无活性。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验